The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

24 Aug 2010 07:00

INTERSERVE APPOINTED TO £4.5bn PROCURE21+ NHS FRAMEWORK AGREEMENT

Interserve, the international services, maintenance and building group, has been named as one of the six Principal Supply Chain Partners (PCSPs) in the new ProCure21+ framework agreement, estimated to be worth up to £4.5 billion over its six-year term.

ProCure21+ will begin operating on 1st October 2010. It is a new framework that will replace the current ProCure21 programme through which Interserve has undertaken 136 schemes on behalf of 52 NHS Trusts since its pilot in 2002. Like ProCure21 the framework will streamline and improve the procurement process for NHS Trusts across England. This will enable them to select an appropriate supply chain partner to deliver acute, primary care and mental health facilities. As with ProCure21, there is a commitment to long-term relationships, collaborative working, integrated supply chains and the use of target-cost contracts.

There are a number of new features in ProCure21+ including:

* A centrally-provided risk evaluation tool for all schemes to improve

consistency and share approaches to managing common risks.

* A central repository of technical drawings and information that can be

re-used by all clients and supply-chain members under the "NHS Royalty-Free

Licence".

* An online "monthly monitoring" performance management system with a reduced

benchmarking data set to manage scheme performance centrally.

* Provision of a project start-up workshop by PCSPs on all schemes to align

stakeholder and supply chain requirements early in the process.

* Assurance of a VAT-compliant PSCP structure to maximise VAT recovery for

NHS Clients.

Commenting on Interserve's selection as a Principal Supply Chain Partner, Adrian Ringrose, Chief Executive, said, "The creation of ProCure21+ is excellent news. Under ProCure21 Interserve has been able to deliver many high-quality, value-for-money facilities and ProCure21+ will enable us to continue enhancing the health environment to meet the changing needs of the NHS. We are well positioned to do this as the only Health Framework Partner supporting the NHS across England, Scotland and Wales."

- Ends -

For further information please contact:

Amanda Cardall 0121 331 8125 Corporate Marketing Manager Elizabeth Morley / Tom Eckersley 020 7379 5151

Maitland About Interserve

Over the last five years Interserve has delivered healthcare projects with a total value of approximately £500 million, most of which has been through ProCure21.

Interserve's vision is to be the Trusted Partner of all our stakeholders. We are one of the world's foremost support services and construction companies, operating in the public and private sectors in the UK and internationally. We offer advice, design, construction and facilities management services for society's infrastructure and provide a range of plant and equipment in specialist fields. Interserve is based in the UK. It has revenue of £1.9 billion and a workforce of 50,000 people worldwide.

Health website: www.health.interserve.com

General website: www.interserve.com.

vendor
Date   Source Headline
15th Mar 20196:27 pmRNSInterserve
15th Mar 20195:56 pmRNSSuccessful completion of sale of the Group
15th Mar 20192:47 pmRNSHolding(s) in Company
15th Mar 20192:01 pmRNSParent Company Administration
15th Mar 201912:33 pmRNSResult of General Meeting
14th Mar 201911:41 amRNSTotal Voting Rights and Warrant Update
14th Mar 20199:18 amRNSDirector/PDMR Shareholding
12th Mar 20198:30 amRNSBlock Listing Application
11th Mar 20195:27 pmRNSResponse to media reports re Deleveraging Plan
5th Mar 201912:56 pmRNSResponse to proposal Coltrane Asset Management L.P
4th Mar 20196:03 pmRNSUpdate on Coltrane Asset Management L.P Proposal
28th Feb 20199:58 amRNSPublication of a Prospectus
27th Feb 20199:05 amRNSDeleveraging Plan details and launch
27th Feb 20198:58 amRNSFull Year Results 2018
26th Feb 20194:17 pmRNSNotice of Requisition General Meeting
22nd Feb 20193:54 pmRNSHolding(s) in Company
22nd Feb 20193:50 pmRNSUpdate on Deleveraging Plan
20th Feb 20199:56 amRNSHolding(s) in Company
19th Feb 201910:13 amRNSHolding(s) in Company
13th Feb 20194:25 pmRNSDirector/PDMR Shareholding
12th Feb 20197:00 amRNSDirectorate Change
6th Feb 20197:10 amRNSStatement re Shareholder Requisition
6th Feb 20197:00 amRNSStatement re Deleveraging Plan
24th Jan 201912:07 pmRNSSecond Price Monitoring Extn
24th Jan 201912:02 pmRNSPrice Monitoring Extension
16th Jan 20191:14 pmRNSDirector/PDMR Shareholding
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 201912:30 pmRNSHolding(s) in Company
2nd Jan 20197:00 amRNSBlock listing Interim Review
28th Dec 20184:20 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSProgress on Deleveraging Plan
17th Dec 20182:52 pmRNSDirector/PDMR Shareholding
10th Dec 20189:30 amRNSInterserve Awarded £25m Contract.
10th Dec 20187:00 amRNSDELEVERAGING PLAN
29th Nov 20182:30 pmRNSHolding(s) in Company
28th Nov 201810:50 amRNSHolding(s) in Company
27th Nov 20183:59 pmRNSHolding(s) in Company
23rd Nov 20182:07 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNS3rd Quarter Update
16th Nov 20184:12 pmRNSHolding(s) in Company
16th Nov 20184:09 pmRNSHolding(s) in Company
13th Nov 20182:50 pmRNSStatement following recent press coverage
13th Nov 201811:00 amRNSDirector/PDMR Shareholding
23rd Oct 201811:03 amRNSHolding(s) in Company
22nd Oct 20184:27 pmRNSHolding(s) in Company
17th Oct 20189:04 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSSALE OF ACCESS AND HARD SERVICES BUSINESS
1st Oct 20189:27 amRNSHolding(s) in Company
14th Sep 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.